Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 13 de 13
Filter
Add more filters










Publication year range
1.
Vet Rec ; 187(7): e50, 2020 Oct 03.
Article in English | MEDLINE | ID: mdl-32430390

ABSTRACT

BACKGROUND: Biologically appropriate raw food (BARF) diet is becoming more and more popular among pet owners in Europe. However, there are documented microbiological risks associated with raw feeding, and this study aimed to determine the presence of human pathogens in commercially frozen BARF products sold in Italy. METHODS: Salmonella species, Escherichia coli O157:H7, Listeria monocytogenes and Campylobacter species were identified. The general microbiological quality of BARF products and hygiene were also evaluated. Sample size was limited and therefore the study may not be representative of a larger sample. RESULTS: None of the tested samples showed total bacterial count (TBC) higher than the limit set to consider a sample unacceptable. However, 14 out of 21 samples showed TBC higher than the limit set to consider a sample marginally acceptable. A high percentage of samples were contaminated by the aforementioned pathogens, highlighting the need for pet owners to be aware of the risks of this feeding strategy both to themselves and to their pets. CONCLUSIONS: Considering that BARF diet meals can be prepared at home using the hands, as well as tools and spaces that could be shared, guidelines on safer handling of these pet food products should be recommended by veterinarians and nutritionists.


Subject(s)
Diet/veterinary , Food Microbiology/statistics & numerical data , Frozen Foods/microbiology , Raw Foods/microbiology , Animals , Campylobacter/isolation & purification , Commerce , Diet/adverse effects , Escherichia coli O157/isolation & purification , Humans , Italy , Listeria monocytogenes/isolation & purification , Pets , Salmonella/isolation & purification
2.
Rejuvenation Res ; 21(1): 37-43, 2018 Feb.
Article in English | MEDLINE | ID: mdl-28498017

ABSTRACT

The interventions to slow aging, favoring active life expectancy, represent the new perspectives in ageing investigation. Some mechanisms that delay or prevent the onset of aging pathologies have been identified. Between them, a healthy lifestyle seems to reduce many risk factors. In particular, eating habits represent the most concrete, low-cost way to act on aging process. Mediterranean diet has received much attention since its antioxidant and anti-inflammatory effects have been consistently demonstrated. Unfortunately, many people follow a Western diet, poor in phytochemicals that represent the main source of beneficial effects of this dietary pattern. So, supplements administration should be considered, especially in subjects exposed to high level of oxidative stress and inflammation. So, we tested the properties of a commercial food supplement containing a series of plant polyphenols in combination with caffeine, bioperine (black pepper extract), and selenium in smoking healthy volunteers. Fifty participants have been recruited and hematochemical analyses and biochemistry tests have been performed, before and after 60 days of supplement intake. Thirteen subjects dropped out of the study. At the end of the intervention, the variation of inflammatory and oxidant markers has been evaluated, measuring urinary isoprostanes, serum advanced glycation end products, and oxidized low-density lipoproteins. The results showed that this supplement exhibits promising antioxidant and anti-inflammatory responses, especially in women, highlighting the role of supplementation in certain groups of subjects, for the control of oxidative stress as well as inflammatory status. So, its intake should be useful in delaying the onset of age-related diseases.


Subject(s)
Diet, Mediterranean , Dietary Supplements , Smoking , Anthropometry , Female , Glycation End Products, Advanced/metabolism , Health , Humans , Isoprostanes/metabolism , Lipoproteins, LDL/metabolism , Male , Middle Aged
3.
Immun Ageing ; 13: 14, 2016.
Article in English | MEDLINE | ID: mdl-27057204

ABSTRACT

BACKGROUND: It is well known that Mediterranean Diet can positively influence the health of each individual, in particular it is know that fibers have an important role. However, in Mediterranean cities most people do not have a close adherence to Mediterranean diet. Thus, in our study, we considered fibers like ß-glucans that have been added to pasta with a percentage of 6 %. Our study aimed to evaluate the capacity of ß-glucans intake on oxidative stress and inflammation in a cohort of middle aged slightly overweight subjects. METHODS: We used a longitudinal study design. The study lasted 30 days during which time, each participant acted with no food restriction. Participants underwent morning fasting blood venous sample for blood chemistry and other biological parameters at the beginning of the study and after 30 days of pasta supplemented with 6 % of ß-glucan intake 4 times a week. We performed anthropometric, biochemical, oxidative stress and cytokine analysis at the beginning and the end of study. RESULTS: After the 30 days of pasta intake we obtained a significant decrease of LDL-cholesterol, IL-6 and AGEs levels. CONCLUSION: The results confirmed a capacity of ß-glucans intake to lower oxidative stress. Additional longitudinal observation on community-based cohorts are needed to confirm these data and investigate the biological mechanisms through which effects are induced, and to fully explore the therapeutic potential of ß-glucans.

4.
Biochim Biophys Acta ; 1853(5): 1046-59, 2015 May.
Article in English | MEDLINE | ID: mdl-25667085

ABSTRACT

Clinical and experimental biomedical studies have shown Type 2 diabetes mellitus (T2DM) to be a risk factor for the development of Alzheimer's disease (AD). This study demonstrates the effect of metformin, a therapeutic biguanide administered for T2DM therapy, on ß-amyloid precursor protein (APP) metabolism in in vitro, ex vivo and in vivo models. Furthermore, the protective role of insulin against metformin is also demonstrated. In LAN5 neuroblastoma cells, metformin increases APP and presenilin levels, proteins involved in AD. Overexpression of APP and presenilin 1 (Pres 1) increases APP cleavage and intracellular accumulation of ß-amyloid peptide (Aß), which, in turn, promotes aggregation of Aß. In the experimental conditions utilized the drug causes oxidative stress, mitochondrial damage, decrease of Hexokinase-II levels and cytochrome C release, all of which lead to cell death. Several changes in oxidative stress-related genes following metformin treatment were detected by PCR arrays specific for the oxidative stress pathway. These effects of metformin were found to be antagonized by the addition of insulin, which reduced Aß levels, oxidative stress, mitochondrial dysfunction and cell death. Similarly, antioxidant molecules, such as ferulic acid and curcumin, are able to revert metformin's effect. Comparable results were obtained using peripheral blood mononuclear cells. Finally, the involvement of NF-κB transcription factor in regulating APP and Pres 1 expression was investigated. Upon metformin treatment, NF-κB is activated and translocates from the cytoplasm to the nucleus, where it induces increased APP and Pres 1 transcription. The use of Bay11-7085 inhibitor suppressed the effect of metformin on APP and Pres 1 expression.


Subject(s)
Amyloid beta-Peptides/metabolism , Amyloid beta-Protein Precursor/metabolism , Insulin/pharmacology , Metformin/pharmacology , Mitochondria/metabolism , NF-kappa B/metabolism , Oxidative Stress/drug effects , Adenylate Kinase/metabolism , Adult , Amyloid Precursor Protein Secretases/metabolism , Animals , Antioxidants/pharmacology , Aspartic Acid Endopeptidases/metabolism , Brain/drug effects , Brain/metabolism , Brain/pathology , Cell Line, Tumor , Cell Nucleus/drug effects , Cell Nucleus/metabolism , Cytoprotection/drug effects , Gene Expression Regulation/drug effects , Humans , Hydrogen Peroxide/pharmacology , Leukocytes, Mononuclear/drug effects , Leukocytes, Mononuclear/metabolism , Male , Mice, Inbred C57BL , Mitochondria/drug effects , Models, Biological , Presenilin-1/metabolism , Protein Transport/drug effects
5.
Gerontology ; 60(6): 508-18, 2014.
Article in English | MEDLINE | ID: mdl-25170545

ABSTRACT

Traditional Mediterranean diet (MedDiet) is a common dietary pattern characterizing a lifestyle and culture proven to contribute to better health and quality of life in Mediterranean countries. By analyzing the diet of centenarians from the Sicani Mountains and eating habits of inhabitants of Palermo, it is reported that a close adherence to MedDiet is observed in the countryside, whereas in big towns this adherence is not so close. This has an effect on the rates of mortality at old age (and reciprocally longevity) that are lower in the countryside than in big towns. Concerning the health effects of the diet, the low content of animal protein and the low glycaemic index of the Sicilian MedDiet might directly modulate the insulin/IGF-1 and the mTOR pathways, known to be involved in ageing and longevity. In particular, the reduction of animal protein intake may significantly reduce serum IGF-1 concentrations and inhibit mTOR activity with a down-regulation of the signal that leads to the activation of FOXO3A and, consequently, to the transcription of homeostatic genes that favour longevity. The down-regulation of both IGF-1 and mTORC1 also induces an anti-inflammatory effect. In addition to the effects on sensing pathways, many single components of MedDiet are known to have positive effects on health, reducing inflammation, optimizing cholesterol and other important risk factors of age-related diseases. However, a key role is played by polyphenols represented in high amount in the Sicilian MedDiet (in particular in extra virgin olive oil) that can work as hormetins that provide an environmental chemical signature regulating stress resistance pathways such as nuclear factor erythroid 2-related factor 2.


Subject(s)
Diet, Mediterranean , Feeding Behavior , Health Status , Life Style , Longevity/physiology , Humans , Sicily
6.
Curr Vasc Pharmacol ; 12(5): 735-8, 2014.
Article in English | MEDLINE | ID: mdl-24350926

ABSTRACT

The Mediterranean diet (Mediet) is an eating pattern characterizing a lifestyle and culture that has been reported to contribute to better health and quality of life. The Mediet reflects food patterns typical of Mediterranean regions, where olive oil plays an essential role in the food pyramid. Olive oil is located in the middle and it is considered the principal source of dietary fat because of its high nutritional quality (particularly extra virgin olive oil). Several studies have shown the effect of the Mediet on healthy status by lowering the rates of coronary heart disease, certain cancers, and some other age-related chronic diseases. Although the scientific literature regarding diet and life span is complex and with different opinions, there are studies that demonstrate the beneficial effects of the Mediet on longevity. Therefore, the Mediet may be considered as including several nutraceuticals that favourably influence health. In the present review we discuss two Mediterranean populations from the island of Ikaria (Greece) and the Sicani Mounts (Sicily, Italy) whose longevity is attributed to a close adherence to the Mediet.


Subject(s)
Diet, Mediterranean/ethnology , Dietary Supplements , Feeding Behavior/ethnology , Feeding Behavior/physiology , Life Style/ethnology , Longevity/physiology , Animals , Dietary Fats/administration & dosage , Humans , Olive Oil , Plant Oils/administration & dosage
7.
Inflammation ; 37(3): 639-48, 2014 Jun.
Article in English | MEDLINE | ID: mdl-24292800

ABSTRACT

Neurodegenerative diseases such as Alzheimer, Parkinson, amyotrophic lateral sclerosis, and Huntington are incurable and debilitating conditions that result in progressive death of the neurons. The definite diagnosis of a neurodegenerative disorder is disadvantaged by the difficulty in obtaining biopsies and thereby to validate the clinical diagnosis with pathological results. Biomarkers are valuable indicators for detecting different phases of a disease such as prevention, early onset, treatment, progression, and monitoring the effect of pharmacological responses to a therapeutic intervention. Inflammation occurs in neurodegenerative diseases, and identification and validation of molecules involved in this process could be a strategy for finding new biomarkers. The ideal inflammatory biomarker needs to be easily measurable, must be reproducible, not subject to wide variation in the population, and unaffected by external factors. Our review summarizes the most important inflammation biomarkers currently available, whose specificity could be utilized for identifying and monitoring distinctive phases of different neurodegenerative diseases.


Subject(s)
Inflammation Mediators/metabolism , Neurodegenerative Diseases/diagnosis , Biomarkers , Humans , Inflammation/immunology , Inflammation/pathology
8.
Immunobiology ; 214(8): 703-11, 2009.
Article in English | MEDLINE | ID: mdl-19249121

ABSTRACT

We previously reported that an inhibition of antigen-specific Interferon-gamma release and cytotoxicity occurs after a continuous infusion of an HY immunodominant peptide although this treatment is not able to cause a significant delay of male skin grafts rejection. In vivo administration of high doses of an HY peptide, through mini-osmotic pumps, in naïve female mice was used to study the effects on the male skin grafts rejection. A continuous infusion of 1mg of an HY peptide induces a significant delay of male skin graft rejection. In vitro HY-specific Interferon-gamma release was inhibited adding peptide-specific suppressor cells: the ability to inhibit Interferon-gamma release was evident when two HY peptides were present on the same dendritic cells indicating that the suppressor cells exert "linked-suppression". The phenotype of the suppressor cells is CD8(+)CD28(-) and these cells express more CD62 ligand and FOXP3 than controls. Suppressor cells were able to cause a significant delay of rejection of male skin grafts when injected in naive female mice. The inhibitory effects of these suppressor cells seem to be due to the impairment of antigen presentation; down-regulation of B7 molecules on dendritic cells occurred. Taken all together, our data demonstrate that a continuous infusion of an immunodominant HY peptide induces a T CD8 suppressor subset able to inhibit immune responses to male tissues and cells.


Subject(s)
CD8-Positive T-Lymphocytes/metabolism , Graft Rejection/immunology , Immunosuppression Therapy , Minor Histocompatibility Antigens/immunology , Skin Transplantation , T-Lymphocytes, Regulatory/metabolism , Animals , Antigen Presentation , B7-1 Antigen/genetics , B7-1 Antigen/immunology , B7-1 Antigen/metabolism , CD8-Positive T-Lymphocytes/drug effects , CD8-Positive T-Lymphocytes/immunology , CD8-Positive T-Lymphocytes/pathology , Cytotoxicity, Immunologic/drug effects , Dendritic Cells/drug effects , Dendritic Cells/immunology , Dendritic Cells/metabolism , Dendritic Cells/pathology , E-Selectin , Female , Forkhead Transcription Factors , Graft Rejection/pathology , Graft Rejection/therapy , H-Y Antigen/administration & dosage , Immunodominant Epitopes/administration & dosage , Infusion Pumps , Interferon-gamma/metabolism , Male , Mice , Mice, Inbred C57BL , Minor Histocompatibility Antigens/administration & dosage , Peptide Fragments/administration & dosage , T-Lymphocytes, Regulatory/drug effects , T-Lymphocytes, Regulatory/immunology , T-Lymphocytes, Regulatory/pathology
9.
Am J Respir Cell Mol Biol ; 41(1): 50-8, 2009 Jul.
Article in English | MEDLINE | ID: mdl-19059888

ABSTRACT

In this study, we evaluated the protective effect and therapeutic potential of the prostaglandin E(2) (PGE(2)) synthetic analog 16,16-dimethyl-PGE(2) (dmPGE(2)) in the animal model of pulmonary fibrosis induced by bleomycin. Mice subjected to intratracheal administration of bleomycin (1 mg/kg) received a dmPGE(2) dose of 30 microg/kg/day by continuous subcutaneous infusion. Bronchoalveolar lavage (BAL); immunohistochemical analysis for IL-1, TNF-alpha, and nitrotyrosine; measurement of fluid content in lung; myeloperoxidase activity assay; and lung histology were performed 1 week later. Lung histology and Sircol assay for collagen deposition were performed 3 weeks after treatments. Changes of body weight and survival rate were also evaluated at 1 and 3 weeks. Compared with bleomycin-treated mice, dmPGE(2) co-treated mice exhibited a reduced degree of body weight loss and mortality rate as well as of lung damage and inflammation, as shown by the significant reduction of: (1) lung infiltration by leukocytes; (2) myeloperoxidase activity; (3) IL-1, TNF-alpha, and nitrotyrosine immunostaining; (4) lung edema; and (5) histologic evidence of lung injury and collagen deposition. In a separate set of experiments, dmPGE(2) treatment was started 3 days after bleomycin administration, and the evaluation of lung damage and inflammation was assessed 4 days later. Importantly, delayed administration of dmPGE(2) also was able to protect from inflammation and lung injury induced by bleomycin. These results, indicating that dmPGE(2) is able to prevent and to reduce bleomycin-induced lung injury through its regulatory and anti-inflammatory properties, encourage further research to find new options for the treatment of pulmonary fibrosis.


Subject(s)
16,16-Dimethylprostaglandin E2/pharmacology , Lung Injury/prevention & control , Lung/drug effects , Protective Agents/pharmacology , Pulmonary Fibrosis/prevention & control , 16,16-Dimethylprostaglandin E2/administration & dosage , Animals , Bleomycin , Body Weight/drug effects , Bronchoalveolar Lavage Fluid/cytology , Collagen/metabolism , Disease Models, Animal , Infusions, Subcutaneous , Interleukin-1beta/metabolism , Lung/immunology , Lung/pathology , Lung Injury/chemically induced , Lung Injury/immunology , Lung Injury/pathology , Male , Mice , Peroxidase/metabolism , Pneumonia/chemically induced , Pneumonia/prevention & control , Protective Agents/administration & dosage , Pulmonary Edema/chemically induced , Pulmonary Edema/prevention & control , Pulmonary Fibrosis/chemically induced , Pulmonary Fibrosis/immunology , Pulmonary Fibrosis/pathology , Time Factors , Tumor Necrosis Factor-alpha/metabolism , Tyrosine/analogs & derivatives , Tyrosine/metabolism
11.
Vet Immunol Immunopathol ; 108(1-2): 247-51, 2005 Oct 18.
Article in English | MEDLINE | ID: mdl-16144718

ABSTRACT

Toxocara canis (T. canis) is originally a parasite of canine bitches and their pups. The pathogenicity of T. canis infection is enhanced during pregnancy and puppyhood. The aim of this study was to investigate if modification of IFNgamma and IL-10 secretion occurs during infection in pregnant dogs and puppies. Analysis of cytokines secreted could let us hypothesize a role for IL-10 and/or IFNgamma in T. canis infection. We tested T. canis-specific production of IFNgamma and IL-10 by lymphocytes of pregnant dogs and their puppies after in vitro re-exposure to purified excretory/secretory antigen (ESAg) from T. canis. Blood mononuclear cells (BMC) isolated from pregnant dogs and their puppies were cultured in the presence of ESAg. Cultures' supernatants were tested for cytokine levels by ELISA. Results obtained showed that IL-10 concentrations increased during pregnancy in infected animals and in the meantime IFNgamma production decreased. In puppyhood, we observed that, IL-10 concentration decreased with the age of puppies mainly in infected animals while IFNgamma increased. In conclusion, our data suggests that BMC of infected dogs have a particular modification of IL-10 and IFNgamma synthesis. These data could be the basis to design immunotherapeutic approaches.


Subject(s)
Dog Diseases/immunology , Interferon-gamma/biosynthesis , Interleukin-10/biosynthesis , Pregnancy Complications, Parasitic/veterinary , Toxocara canis , Toxocariasis/immunology , Animals , Antigens, Helminth , Dogs , Female , In Vitro Techniques , Pregnancy , Pregnancy Complications, Parasitic/immunology , Toxocara canis/immunology , Toxocariasis/complications
12.
Immunol Lett ; 98(2): 245-52, 2005 May 15.
Article in English | MEDLINE | ID: mdl-15860224

ABSTRACT

Transgenic mice expressing human major histocompatibility complex (MHC) class II molecules would provide a valuable model system for studying murine anti-human MHC immune response. We have previously shown that skin from HLA-DR1 transgenic mice was rejected by control littermates and spleen cells from rejecting mice were able to proliferate to donor cells. The aim of this paper is to analyze the mechanism of recognition of this xenoantigen and the possible involvement of antibody response in anti-HLA-DR1 immune response. Control littermates were immunized with spleen cells from HLA-DR1 transgenic (TG) mice; at indicated times, xenoantigen-specific proliferation and IFNgamma production was assessed using APC obtained from HLA-DR1 TG mice. Mixed direct-indirect pathway of xenoantigen recognition was suggested by the following findings: i)T cell response to HLA-DR1 was inhibited adding in culture monoclonal antibodies directed either to donor (HLA-DR) or to recipient MHC (I-A); ii) APC from control mice pulsed with purified DR1 molecules were able to induce proliferation by FVB/N mice immunized with transgenic spleen cells. HLA-DR1 recognition permits DR peptide-specific T cell response by lymphocytes of control littermates immunized with the xenoantigen. In addition, we detected xenoreactive IgM and IgG2 antibodies. Our data suggest that HLA-DR1 xenoantigen may be recognized through direct or indirect pathway and provide additional information on mouse anti-human HLA immune response.


Subject(s)
Antibody Formation , Antigens, Heterophile/immunology , HLA-DR1 Antigen/immunology , T-Lymphocytes/immunology , Animals , Cell Proliferation , Epitopes, T-Lymphocyte/immunology , Female , HLA-DR1 Antigen/genetics , Humans , Immunoglobulin G/blood , Immunoglobulin G/immunology , Immunoglobulin M/blood , Immunoglobulin M/immunology , Interferon-gamma/biosynthesis , Male , Mice , Mice, Transgenic , Peptide Fragments/immunology , Spleen/cytology , Spleen/immunology
13.
J Infect Dis ; 186(12): 1835-9, 2002 Dec 15.
Article in English | MEDLINE | ID: mdl-12447771

ABSTRACT

Vgamma9/Vdelta2 T cells can contribute to protective immune response against Mycobacterium tuberculosis, although the extent to which and mechanisms by which they could actually protect against human tuberculosis remain unclear. We have previously reported that Vgamma9/Vdelta2 T cells from tuberculin purified protein derivative (PPD)-positive children, either healthy or affected by different clinical forms of tuberculosis, strongly proliferate to different phosphoantigens in vitro, whereas Vgamma9/Vdelta2 T cells from PPD-negative healthy subjects proliferate very poorly. We report here that Vgamma9/Vdelta2 T cells from tuberculous children have an increased proliferative activity, but decreased interferon (IFN)-gamma production and granulysin expression. After successful chemotherapy, the Vgamma9/Vdelta2 T cell proliferative response strongly decreased, whereas IFN-gamma and granulysin production consistently increased. Disease-associated changes in Vgamma9/Vdelta2 T cell effector functions in patients with tuberculosis are consistent with the possibility that these T cells may play a protective role in immune response against M. tuberculosis infection.


Subject(s)
Mycobacterium tuberculosis , Receptors, Antigen, T-Cell, gamma-delta/analysis , T-Lymphocytes/immunology , Tuberculosis/immunology , Adolescent , Antigens, Differentiation, T-Lymphocyte/biosynthesis , Antitubercular Agents/therapeutic use , Child , Child, Preschool , Female , Humans , Infant , Interferon-gamma/biosynthesis , Male , Tuberculin Test , Tuberculosis/blood , Tuberculosis/drug therapy
SELECTION OF CITATIONS
SEARCH DETAIL
...